Reductions in liver enzymes are associated with anti‐hyperglycaemic and anti‐obesity effects of tofogliflozin in people with type 2 diabetes: Post‐hoc analyses

Reductions in liver enzymes are associated with anti‐hyperglycaemic and anti‐obesity effects of tofogliflozin in people with type 2 diabetes: Post‐hoc analyses

Abstract Aims How the pathology of type 2 diabetes (T2D), including hyperglycaemia and obesity, affects liver enzymes has not been clinically demonstrated. Thus, we compared time courses of gamma‐glutamyltransferase (GGT) and alanine aminotransferase (ALT) with those of fasting plasma glucose (FPG)...

Full description

Bibliographic Details
Main Authors: Toshinari Takamura, Kohei Kaku, Akihiro Yoshida, Hiromi Kusakabe, Hiroyuki Nakamura, Hideki Suganami
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
alanine aminotransferase
fatty liver
gamma‐glutamyltransferase
sodium/glucose cotransporter 2 inhibitor
tofogliflozin
Online Access:https://doi.org/10.1002/edm2.461

Similar Items

Similar Items